Skip to main content

Telomir Pharmaceuticals, Inc.

TELO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001971532

No open-market purchases or sales by Telomir Pharmaceuticals, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $3.80M in total; no superinvestor holds it.

Superinvestors holding TELO, Q2 2026

See all superinvestors

No superinvestor reported holding TELO in Q2 2026.